Company Number: NI668358

Analysis Date: 2025-07-20 13:49 UTC

1. Risk Rating: MEDIUM
   Troleige Limited shows signs of improved solvency with a slight positive net current asset position as of August 2024, following prior years of negative working capital and shareholder deficits. However, overall financial scale is very small with limited capital, and historical volatility in net assets and liabilities suggests some operational and liquidity risk remains.

2. Key Concerns:

• Low Capitalization: Share capital is nominal (£10), and shareholders’ funds remain minimal at £398, indicating limited equity buffer to absorb shocks.
• Fluctuating Working Capital: The company moved from a negative net current assets position in prior years to a slight positive of £398 in 2024, reflecting marginal liquidity improvement but still very tight working capital.
• Related Party Debt: Significant creditor balance (£5,274) owed to group undertakings may indicate reliance on intra-group financing which could pose risk if group support weakens.

3. Positive Indicators:

• Current Accounts Up to Date: No overdue filings for accounts or confirmation statements, indicating regulatory compliance and timely governance.
• Cash Reserves Stable: Cash on hand remains relatively consistent (£8,753 in 2024) supporting short-term liquidity.
• Business Continuity: Active status and no administration or liquidation proceedings suggest operational continuity.

4. Due Diligence Notes:

• Investigate nature and terms of amounts owed to group undertakings and other creditors to assess refinancing or repayment risk.
• Review turnover, profitability, and cash flow trends (not disclosed here) to understand underlying operational performance and sustainability.
• Confirm the company's business model and market position within "Other human health activities" (SIC 86900) to evaluate operational stability and growth prospects.
• Assess director’s plans for capital injection or debt restructuring to strengthen solvency further.